Spontaneous pneumothorax and pneumomediastinum in patients with COVID‐19: A case series from Iran
Clinical case reports
; 10(2), 2022.
Article
in English
| EuropePMC | ID: covidwho-1679272
ABSTRACT
Here, we report six cases of spontaneous pneumothorax and pneumomediastinitis in patients with COVID‐19 in Iran, which were treated with different drugs such as hydroxychloroquine, sofosbuvir, atazanavir, and remdesivir as antiviral agents. Despite the differences in the type of drugs, pneumothorax occurred in all patients. Chest CT can provide useful information in patients with COVID‐19‐associated pneumonia. Pneumothorax and pneumomediastinum may develop in COVID‐19‐associated pneumonia due to alveolar damage. Pneumothorax and pneumomediastinum may be the first symptom of COVID‐19 or a late complication. Pneumothorax and pneumomediastinum may appear in the patients with different antiviral therapy.
Search on Google
Collection:
Databases of international organizations
Database:
EuropePMC
Language:
English
Journal:
Clinical case reports
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS